Concordia Healthcare Corp Price Target Raised to C$40.00 (CXR)
Research analysts at Canaccord Genuity raised their target price on shares of Concordia Healthcare Corp (TSE:CXR) from C$38.00 to C$40.00 in a report released on Thursday. Canaccord Genuity’s price objective indicates a potential upside of 8.20% from the stock’s previous close.
Shares of Concordia Healthcare Corp (TSE:CXR) traded down 0.70% during mid-day trading on Thursday, hitting $36.71. 706,995 shares of the company’s stock traded hands. Concordia Healthcare Corp has a one year low of $2.404 and a one year high of $48.08. The stock has a 50-day moving average of $35.27 and a 200-day moving average of $27.76. The company has a market cap of $1.047 billion and a P/E ratio of 94.79.
Concordia Healthcare Corp (TSE:CXR) last posted its quarterly earnings results on Thursday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by $0.22. Analysts expect that Concordia Healthcare Corp will post $1.25 EPS for the current fiscal year.
Concordia Healthcare Corp., formerly Mercari Acquisition Corp., is an integrated, specialty healthcare company focused on the acquisition of pharmaceutical products and medical devices and the acquisition and/or development of orphan drugs.
Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.